IL13 and primary cutaneous T-cell non-Hodgkin lymphoma: It is interesting that the blocking antibody to the IL-4 receptor, dupilumab, has been shown to unmask (CTCL misdiagnosed as AD) or worsen CTCL symptoms61, possibly by increasing free IL-4 and IL-13 to bind to the IL-13α2 receptor62,63.